세계의 채혈 기기 시장 : 제품, 방법, 재료, 용도, 최종 사용자별 예측(2025-2030년)

The Blood Collection Devices Market was valued at USD 7.63 billion in 2023, expected to reach USD 8.15 billion in 2024, and is projected to grow at a CAGR of 7.32%, to USD 12.52 billion by 2030.

The scope and definition of the Blood Collection Devices market encompass a broad range of tools and equipment used predominantly in medical settings to collect blood samples for testing, transfusions, and other health-related purposes. The necessity of these devices emerges from the escalating demand for accurate and reliable diagnostic screening, health assessments, and the effective management of diseases like diabetes and leukemia. Applications span hospitals, diagnostic centers, and even home use, facilitated by an uptick in self-monitoring gadgets. End-use sectors include healthcare facilities, pharmaceutical companies, and research organizations, where precise blood sample collection is vital for treatment and medicinal innovation. Key growth factors include technological advancements in blood collection techniques and devices, rising prevalence of chronic diseases, and increased awareness about regular health check-ups. Latest opportunities lie in the development of increasingly painless and user-friendly devices, such as micro-needles and closed blood collection systems, with an expanding market in emerging economies due to improved healthcare infrastructure. However, limitations such as apprehensions about bloodborne infections, needle stick injuries, and the high costs associated with advanced devices introduce challenges for market growth. Regulatory complexities and compliance issues also present hurdles. Innovations in the industry could focus on the integration of digital health technologies with blood collection devices for real-time data tracking and analysis, potentially revolutionizing at-home diagnostics and personalized medicine. Emphasizing environmental sustainability by developing eco-friendly devices with biodegradable materials can also provide a competitive edge. The nature of the market is dynamic and competitive, driven by continuous technological progress and a shift towards minimally invasive techniques. To capitalize on these trends, companies should invest in strategic partnerships, leverage AI and machine learning for predictive analytics, and ensure adaptive R&D to keep pace with technological breakthroughs and evolving consumer expectations.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Blood Collection Devices Market

The Blood Collection Devices Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Rising cases of accidents or trauma cases with need for complex surgeries
  • Demand for blood components and blood donations
  • Availability of custom-designed blood collection devices
• Market Restraints
  • Surging incidence of blood collection device recall
• Market Opportunities
  • Advancements in blood collection and sampling technologies
  • Establishments of new blood testing laboratories worldwide
• Market Challenges
  • Improper design of blood collection devices and inaccuracy of results

Porter's Five Forces: A Strategic Tool for Navigating the Blood Collection Devices Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Blood Collection Devices Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Blood Collection Devices Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Blood Collection Devices Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Blood Collection Devices Market

A detailed market share analysis in the Blood Collection Devices Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Blood Collection Devices Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Blood Collection Devices Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Blood Collection Devices Market

A strategic analysis of the Blood Collection Devices Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Blood Collection Devices Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, AdvaCare Pharma, Avanos Medical, Inc., Avantor, Inc., B. Braun SE, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Biosigma S.p.A., Cardinal Health, Inc., Exelint International, Co., Fresenius SE & Co. KGaA, Greiner AG, Haemonetics Corporation, ICU Medical, Inc., ITL Health Group, Kawasumi Laboratories America, Inc., Lasany International, Medtronic PLC, Nipro Corporation, Qiagen N.V., Sarstedt AG & Co. KG, Sekisui Medical Co., Ltd., Siemens Healthineers AG, Terumo Corporation, and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Blood Collection Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Blood Collection Needles/Holders, Blood Collection System, Blood Collection Tubes, and Lancet. The Blood Collection Tubes is further studied across Plasma Blood Tubes and Serum Tubes.
• Based on Method, market is studied across Automated Blood Collection and Manual Blood Collection.
• Based on Material, market is studied across Glass, Plastic, Rubber, and Stainless Steel.
• Based on Application, market is studied across Diagnostic and Therapeutics.
• Based on End-user, market is studied across Blood Donation Centers, Diagnostic & Pathology Laboratory, and Hospitals & Clinics.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Bolivia, Brazil, Canada, Chile, Colombia, Costa Rica, Dominican Republic, Ecuador, Guatemala, Mexico, Panama, Paraguay, Peru, Puerto Rico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising cases of accidents or trauma cases with need for complex surgeries
    • 5.1.1.2. Demand for blood components and blood donations
    • 5.1.1.3. Availability of custom-designed blood collection devices
  • 5.1.2. Restraints
    • 5.1.2.1. Surging incidence of blood collection device recall
  • 5.1.3. Opportunities
    • 5.1.3.1. Advancements in blood collection and sampling technologies
    • 5.1.3.2. Establishments of new blood testing laboratories worldwide
  • 5.1.4. Challenges
    • 5.1.4.1. Improper design of blood collection devices and inaccuracy of results
• 5.2. Market Segmentation Analysis
  • 5.2.1. Product: Ongoing advancements blood collection systems to facilitate a seamless collection process
  • 5.2.2. Application: Growing awareness about early diagnosis driving the innovations of blood collection devices
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Blood Collection Devices Market, by Product

• 6.1. Introduction
• 6.2. Blood Collection Needles/Holders
• 6.3. Blood Collection System
• 6.4. Blood Collection Tubes
  • 6.4.1. Plasma Blood Tubes
  • 6.4.2. Serum Tubes
• 6.5. Lancet

7. Blood Collection Devices Market, by Method

• 7.1. Introduction
• 7.2. Automated Blood Collection
• 7.3. Manual Blood Collection

8. Blood Collection Devices Market, by Material

• 8.1. Introduction
• 8.2. Glass
• 8.3. Plastic
• 8.4. Rubber
• 8.5. Stainless Steel

9. Blood Collection Devices Market, by Application

• 9.1. Introduction
• 9.2. Diagnostic
• 9.3. Therapeutics

10. Blood Collection Devices Market, by End-user

• 10.1. Introduction
• 10.2. Blood Donation Centers
• 10.3. Diagnostic & Pathology Laboratory
• 10.4. Hospitals & Clinics

11. Americas Blood Collection Devices Market

• 11.1. Introduction
• 11.2. Argentina
• 11.3. Bolivia
• 11.4. Brazil
• 11.5. Canada
• 11.6. Chile
• 11.7. Colombia
• 11.8. Costa Rica
• 11.9. Dominican Republic
• 11.10. Ecuador
• 11.11. Guatemala
• 11.12. Mexico
• 11.13. Panama
• 11.14. Paraguay
• 11.15. Peru
• 11.16. Puerto Rico
• 11.17. United States

12. Asia-Pacific Blood Collection Devices Market

• 12.1. Introduction
• 12.2. Australia
• 12.3. China
• 12.4. India
• 12.5. Indonesia
• 12.6. Japan
• 12.7. Malaysia
• 12.8. Philippines
• 12.9. Singapore
• 12.10. South Korea
• 12.11. Taiwan
• 12.12. Thailand
• 12.13. Vietnam

13. Europe, Middle East & Africa Blood Collection Devices Market

• 13.1. Introduction
• 13.2. Denmark
• 13.3. Egypt
• 13.4. Finland
• 13.5. France
• 13.6. Germany
• 13.7. Israel
• 13.8. Italy
• 13.9. Netherlands
• 13.10. Nigeria
• 13.11. Norway
• 13.12. Poland
• 13.13. Qatar
• 13.14. Russia
• 13.15. Saudi Arabia
• 13.16. South Africa
• 13.17. Spain
• 13.18. Sweden
• 13.19. Switzerland
• 13.20. Turkey
• 13.21. United Arab Emirates
• 13.22. United Kingdom

14. Competitive Landscape

• 14.1. Market Share Analysis, 2023
• 14.2. FPNV Positioning Matrix, 2023
• 14.3. Competitive Scenario Analysis
  • 14.3.1. Nipro Innovates in Blood Collection with Introduction of a Novel Air-Free Design
  • 14.3.2. BD Secures FDA 510(k) Clearance for Innovative Fingertip Blood Collection Device
  • 14.3.3. BD's Introduction of Needle-Free Device to Enhance Patient Comfort
  • 14.3.4. Aptar and Tasso's Alliance to Revolutionize Blood Collection with Digital Integration
  • 14.3.5. FDA Grants Clearance to YourBio Health's Innovative Blood Collection Device, Enhancing Efficiency and Patient Experience
  • 14.3.6. Capitainer Unveils Innovative Self-Sampling Blood Collection Kit, Elevating Diagnostic Efficiency
  • 14.3.7. Babson College and BD's Strategic Alliance for Enhanced Accessibility and Efficiency in Healthcare
  • 14.3.8. Owen Mumford's Unveils Innovative Blood Collection Devices Enhancing Safety and Efficiency
  • 14.3.9. Introducing RNA Complete BCT Revolutionizing Blood Collection with Enhanced Cell-Free RNA and Extracellular Vesicle Preservation
• 14.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abbott Laboratories
• 2. AdvaCare Pharma
• 3. Avanos Medical, Inc.
• 4. Avantor, Inc.
• 5. B. Braun SE
• 6. Becton, Dickinson and Company
• 7. Bio-Rad Laboratories, Inc.
• 8. Biosigma S.p.A.
• 9. Cardinal Health, Inc.
• 10. Exelint International, Co.
• 11. Fresenius SE & Co. KGaA
• 12. Greiner AG
• 13. Haemonetics Corporation
• 14. ICU Medical, Inc.
• 15. ITL Health Group
• 16. Kawasumi Laboratories America, Inc.
• 17. Lasany International
• 18. Medtronic PLC
• 19. Nipro Corporation
• 20. Qiagen N.V.
• 21. Sarstedt AG & Co. KG
• 22. Sekisui Medical Co., Ltd.
• 23. Siemens Healthineers AG
• 24. Terumo Corporation
• 25. Thermo Fisher Scientific Inc.